摘要:
The invention describes a composition comprising a) an organic material which is susceptible to oxidative, thermal or light-induced degradation, and b) at least one melt additive of a compound of the formula I R1 (I) R3 X R2 wherein the general symbols are as defined in claim 1. The compounds of the formula I are useful as reducers of surface energy for organic materials, for example, for increasing the oil and water repellency of organic materials.
摘要翻译:本发明描述了一种组合物,其包含a)对氧化,热或光诱导降解敏感的有机材料,和b)式I R1(I)R3 X R2化合物的至少一种熔融添加剂,其中通用符号 如权利要求1中所定义。 式I的化合物可用作有机材料的表面能的还原剂,例如用于增加有机材料的防油和拒水性。
摘要:
The invention describes a composition comprising a) an organic material which is susceptible to oxidative, thermal or light-induced degradation, and b) at least one melt additive of a compound of the formula I R1(I)R3XR2 wherein the general symbols are as defined in claim 1. The compounds of the formula I are useful as reducers of surface energy for organic materials, for example, for increasing the oil and water repellency of organic materials.
摘要:
The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
摘要:
A trocar tube, trocar, obturator, rectoscope is suitable for transluminal endoscopic surgery via natural body cavities. A trocar tube (2) has a distal section (22) for positioning at least in the region of or outside the body cavity, and a proximal section (21) for positioning within the human or animal, wherein at least the proximal section has a substantially rigid or inflexible curvature. An obturator (3) and a rectoscope (5) may be adapted for use with such a trocar tube for this purpose.
摘要:
The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
摘要:
The present invention relates to a method of treating a neurological condition in a mammal by administering at least one hematopoietic growth factor.
摘要:
Provided are cell based methods to identify memory modulating compounds based on the assessment of KIBRA expression. These methods are also suitable to uncover memory related pathways. The methods comprise the contacting of test compounds with cultured cells and the subsequent assessment of modulation of the KIBRA expression within the cells.
摘要:
The present invention relates to the use of tranilast and derivatives thereof for the preparation of a pharmaceutical composition for treating and/or preventing a neuronal condition where there is a need of neuroprotection and neuroregeneration. The invention furthermore relates to the use of tranilast and derivatives thereof for the in vitro differentiation of neuronal stem cells and the use of such pre-treated cells for stem cell therapy von neurological conditions.
摘要:
The present invention relates to a method of treating neurological conditions in a mammal by administering a hematopoietic growth factor such as granulocyte-colony stimulating factor (GCSF) and granulocyte-macrophage colony stimulating factor (GMCSF). The invention also provides methods of screening for compounds that bind to a GCSF or GMCSF receptor found on the surface of a neuronal cell; and which provides a neuroprotective, neuroproliferative and/or a STAT gene activation activity.
摘要:
The present invention relates to (i) DNA sequences, (ii) expression vectors comprising DNA sequences of the invention, (iv) host cells having the expression vectors of the invention, (v) gene products encoded by sequences of the invention, (vi) transgenic animals altered with respect to sequences of the invention, (vii) antibodies directed against gene products of the invention, (viii) methods for expressing and/or isolating gene products of the invention, (ix) the use of DNA sequences and/or gene products of the invention as drugs, (x) pharmaceutically active compounds and methods for preparing them and also uses of such compounds of the invention and (xi) nontherapeutic uses of DNA sequences and/or gene products of the invention.